Stephen Simpson, CFA, is a freelance financial writer and investor.
I have worked for both sell-side and buy-side firms (equities and fixed income), with the largest percentage of my working time spent in med-tech. At this point I am now effectively in a "working retirement".
I write because I find that the process helps me take better notes, be more disciplined about modeling, and come up with a more coherent investment view for my portfolio management needs. If I'm writing about a stock, it's generally because I'm interested in it as an investment prospect or I think there's an interesting story to tell.
I don't share my models, so please don't ask.
More of my writings can be found at my blog Kratisto Investing (kratistoinvesting.blogspot.com), or Twitter (@Kratisto_Invest).
Ashraf Eassa is a technology specialist with The Motley Fool. He writes mostly about technology stocks, but is especially interested in anything related to chips -- the semiconductor kind, that is.
Managing partner at Sand Hill East (www.sandhilleast.net), a VC advisory/investment firm specializing in aiding early stage technology companies.
Started career at Goldman Sachs as research analyst. Worked 10 years on the buyside primarily at Moore Capital and offshoot Pia Capital.
I focus on investments in the oil & gas sector with an eye for dividend income and long-term capital appreciation. I typically allocate a portion of my own portfolio and devote some of my Seeking Alpha articles to small and medium sized companies offering compelling risk/reward propositions.
I am an engineer, not a qualified investment advisor. While the information and data presented in this article were obtained from company documents and/or sources believed to be reliable, they have not been independently verified. Therefore, I cannot guarantee its accuracy. I advise investors conduct their own research and/or consult a qualified investment advisor. I explicitly disclaim any liability that may arise from investment decisions you make based on this article. Thanks for reading and I wish you much success – Michael Fitzsimmons.
Vice President level professional with over six years of experience at a bulge bracket investment bank supporting Securities Sales & Trading. I have an undergraduate degree in Finance and am currently pursuing my MBA with a concentration in Finance as well. I have ten plus years of investing experience utilizing stocks, bonds, ETF’s, mutual funds and options to manage personal and family accounts.
Although all of my professional experience is on the Securities sell-side, I hope to move into a full time asset management/investment analysis role upon graduation from my MBA program. I follow the markets as a whole, from macroeconomic events to equities across the entire market cap spectrum, but my Seeking Alpha research and publications tend to focus on the small and mid-cap space. I believe this is the area in which the most value can be added from an independent and/or buy-side analyst standpoint, given the typical lack of coverage of these companies by most of the larger institutions. I am looking to leverage the Seeking Alpha platform in order to both promote and improve my investment analysis and writing skills, and hope that it could potentially open doors for me.
If you have questions about my publications, would like to know more about me or would just like to bounce around ideas, feel free to message me via Seeking Alpha.
I am a Portuguese independent trader, analyst and algorithmic trading expert, having worked for both sell side (brokerage) and buy side (fund management) institutions.
I've been trading professionally for about 20 years and also launched www.thinkfn.com in 2004. Thinkfn (Think Finance) carries thousands of educational articles on finance and the markets.
I trade futures, stocks from the long and short side, forex and options. I trade both discretionary and fully automated systems (Metatrader, Quantshare and others).
I can be reached at paulo.santosATthinkfn.com or followed on Twitter at twitter.com/ThinkFinance999
Strategic investor/researcher with a primary focus in high percentage gain poised long equity investments. My research areas include the biotech/pharmaceutical sector, precious metals markets, short equities and natural resources.
Full-time investor searching for talented operators, clean capital structures & scalable growth. No cigar butts or conventional wisdom. My investment philosophy is similar to how I live my life: acquire a few prized possessions at the right price, minimize clutter and maintain flexibility. Twitter: @indievestments